Related Experiment Video

Updated: May 14, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Recent advances in drug design of epidermal growth factor receptor inhibitors

P Warnault1, A Yasri, M Coisy-Quivy

  • 1Equipe Molécules Bioactives, Institut de Chimie de Nice, UMR UNS CNRS 7272, Université de Nice Sophia Antipolis, Parc Valrose, 06108 Nice cedex 2, France.

Current Medicinal Chemistry
|February 16, 2013
PubMed

Insights

Targeted therapies using tyrosine kinase inhibitors (TKIs) show promise for solid tumors with specific epidermal growth factor receptor (EGFR) mutations. However, rapid resistance necessitates novel strategies for developing potent EGFR inhibitors.

Area of Science:

  • Oncology
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Epidermal growth factor receptor (EGFR) is a key target in solid tumor therapy.
  • Tyrosine kinase inhibitors (TKIs) offer benefits for patients with specific EGFR mutations.
  • Rapid development of resistance to TKIs limits treatment efficacy.

Purpose of the Study:

  • To review recent advances in the development of TKIs targeting EGFR.
  • To explore rational strategies for designing potent EGFR inhibitors.
  • To highlight the role of molecular modeling and crystallographic data in drug design.

Main Methods:

  • Literature review of recent advances in TKI development.
  • Analysis of strategies for overcoming EGFR inhibitor resistance.
  • Focus on molecular modeling and structure-based drug design.

Main Results:

  • EGFR is crucial in tumor progression, making it a target for therapies.
  • TKIs provide benefits but face rapid resistance.
  • Novel strategies like dual-target inhibitors and combined therapies are being explored.

Conclusions:

  • Advances in TKI development offer new possibilities for EGFR-targeted therapies.
  • Structure-based drug design and molecular modeling are vital for creating potent EGFR inhibitors.
  • Overcoming resistance is key to improving patient outcomes in EGFR-mutated cancers.

More Related Videos

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...